Acute myeloid leukaemia, not elsewhere classified by criteria of other types

Definition

Acute myeloid leukaemias specified by morphological criteria should only be classified as such, if recurrent genetic abnormalities, prior history of a myelodysplastic syndrome or myelodysplastic/myeloproliferative neoplasm, or history of cytotoxic chemotherapy and/or radiotherapy are absent.

Exclusions

• Acute myeloid leukaemia with myelodysplasia-related changes (2A60.1)
• Acute myeloid leukaemia with recurrent genetic abnormalities (2A60.0)
• Therapy-related myeloid neoplasms (2A60.2)

12 subordinate codes

• 2A60.30Acute myeloid leukaemia with minimal differentiation
• 2A60.31Acute myeloid leukaemia without maturation
• 2A60.32Acute myeloid leukaemia with maturation
• 2A60.33Acute myelomonocytic leukaemia
• 2A60.34Acute monoblastic or monocytic leukaemia
• 2A60.35Acute erythroid leukaemia
• 2A60.36Acute megakaryoblastic leukaemia
• 2A60.37Acute basophilic leukaemia
• 2A60.38Acute panmyelosis with myelofibrosis
• 2A60.39Myeloid sarcoma
• 4B4YOther specified diseases of the immune system
• 4B4ZDiseases of the immune system, unspecified

Nearby in Acute myeloid leukaemias and related precursor neoplasms

• 2A60.0Acute myeloid leukaemia with recurrent genetic abnormalities
• 2A60.1Acute myeloid leukaemia with myelodysplasia-related changes
• 2A60.2Therapy-related myeloid neoplasms
• 2A60.4Myeloid proliferation associated with Down syndrome
• 2A60.5Blastic plasmacytoid dendritic cell neoplasm
• 4B4YOther specified diseases of the immune system
• 4B4ZDiseases of the immune system, unspecified